Brincidofovir clearance of acyclovir‐resistant herpes simplex virus‐1 and adenovirus infection after stem cell transplantation
Authors:
- 16 September 2016
- journal article
- case report
- Published by Wiley in Transplant Infectious Disease
- Vol. 18 (5) , 791-794
Abstract
Infections with adenovirus (AdV) and herpesviruses can result in considerable morbidity and mortality in pediatric hematopoietic stem cell transplant (SCT) recipients. Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections. We report a child with myelodysplastic syndrome undergoing multiple SCT, who experienced HSV‐1 disease including severe mucositis and herpetic whitlow, as well as high viral load AdV DNAemia. Both ACV and CDV were ineffective; however, viral loads were decreased with brincidofovir, resulting in viral clearance. A subsequent Epstein–Barr virus disease with relevant meningoencephalitis responded to rituximab.Keywords
This publication has 18 references indexed in Scilit:
- Herpes simplex virus and varicella zoster virusCurrent Opinion in Infectious Diseases, 2015
- Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2Journal of Antimicrobial Chemotherapy, 2015
- Development of CMX001 (Brincidofovir) for the treatment of serious diseases or conditions caused by dsDNA virusesExpert Review of Anti-infective Therapy, 2014
- Adenovirus Infections in Immunocompetent and Immunocompromised PatientsClinical Microbiology Reviews, 2014
- Adenovirus: Current Epidemiology and Emerging Approaches to Prevention and TreatmentCurrent Infectious Disease Reports, 2014
- First Pharmacokinetic and Safety Study in Humans of the Novel Lipid Antiviral Conjugate CMX001, a Broad-Spectrum Oral Drug Active against Double-Stranded DNA VirusesAntimicrobial Agents and Chemotherapy, 2012
- CMX001 Potentiates the Efficacy of Acyclovir in Herpes Simplex Virus InfectionsAntimicrobial Agents and Chemotherapy, 2011
- Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and ManagementAntimicrobial Agents and Chemotherapy, 2011
- Use of Long‐Term Suppressive Acyclovir after Hematopoietic Stem‐Cell Transplantation: Impact on Herpes Simplex Virus (HSV) Disease and Drug‐Resistant HSV DiseaseThe Journal of Infectious Diseases, 2007
- Acyclovir Prophylaxis of Herpes-Simplex-Virus InfectionsNew England Journal of Medicine, 1981